No results could be found for this keywords.
No results could be found for this keywords.
All ScienceStage.com Results for
Selegiline
Pubmed Results for
Selegiline
- MAO-inhibitors in Parkinson's Disease - National Center for ...
Monoamine oxidase inhibitors (MAO-I) belong to the earliest drugs tried in Parkinson's disease (PD). They have been used with or without levodopa (L-DOPA). - Medical management of levodopa-associated motor complications in ...
1. CNS Drugs. 2007;21(8):677-92. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. Jankovic J, Stacy M. - Symptomatic pharmacological therapy in Parkinson’s disease ...
Early disease has been used to refer to people with PD who have developed functional disability and require symptomatic therapy. - Antidepressants for depression in stage 3-5 chronic kidney disease ...
1. Nephrol Dial Transplant. 2012 Oct;27(10):3736-45. doi: 10.1093/ndt/gfs295. Epub 2012 Aug 1. Antidepressants for depression in stage 3-5 chronic kidney disease: a ... - Management of sexual dysfunction due to antipsychotic drug therapy.
1. Cochrane Database Syst Rev. 2012 Nov 14;11:CD003546. doi: 10.1002/14651858.CD003546.pub3. Management of sexual dysfunction due to antipsychotic drug therapy. - Therapies in Parkinson's disease. - National Center for ...
1. Curr Opin Neurol. 2012 Aug;25(4):433-47. doi: 10.1097/WCO.0b013e3283542fc2. Therapies in Parkinson's disease. Jankovic J, Poewe W. Department of Neurology ... - Monoamine oxidase B inhibitors for early Parkinson's disease ...
Parkinson's disease is a disabling condition of the brain characterized by slowness of movement, shaking, stiffness, and in the later stages, loss of balance. - Antidepressants for smoking cessation. - National Center for ...
1. Cochrane Database Syst Rev. 2002;(1):CD000031. Antidepressants for smoking cessation. Hughes JR, Stead LF, Lancaster T. Department of Psychiatry, University of ... - Practice parameters for the treatment of narcolepsy and other ...
1. Sleep. 2007 Dec;30(12):1705-11. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Morgenthaler TI, Kapur VK, Brown T ... - Narcolepsy: current treatment options and future approaches
Correspondence: Michel Billiard Department of Neurology, Gui de Chauliac Hospital, 80 Avenue Augustin Fliche, 34295, Montpellier, cedex 5, France Tel +33 6 75 028 364 ...